Introduction
Notch genes have been involved in the regulation of cell fate in a broad spectrum of tissues and species (Artavanis-Tsakonas et al., 1999) . Members of the Notch family (for example, Notch1 and Notch3) have been described to have a critical role in T-cell development (Deftos et al., 1998 (Deftos et al., , 2000 Rothenberg, 2001; Campese et al., 2003) and their constitutive activation has been related to T-cell leukemia development in both animals models (Pear et al., 1996; Bellavia et al., 2000) and human disease (Ellisen et al., 1991; Bellavia et al., 2002) . Our previous findings have suggested a specific role for Notch3 receptor at the pre-T-cell receptor (pre-TCR) checkpoint of intrathymic T-cell differentiation process, resulting in the development of acute T-cell leukemia in Notch3-IC transgenic (tg N3-IC) mice (Bellavia et al., 2000) . We then showed that the combined overexpression of Notch3 and pTa characterizes T-cell acute lymphoblastic leukemia (T-ALL) and that deletion of pTa gene is able to abrogate this leukemogenic process (Bellavia et al., 2002) . However, the molecular mechanisms sustaining Notch3 protein overexpression and the relationships between Notch3 and pTa remain undefined.
Several studies have suggested that proteasomal degradation of activated forms of Notch (Notch-IC) may be required for the negative regulation of Notch signaling (Hubbard et al., 1997; Schweisguth, 1999) . c-Cbl, Itch and Sel-10 are all involved in the negative regulation of Notch signaling (Qiu et al., 2000; Oberg et al., 2001; Wu et al., 2001; Jehn et al., 2002) . In particular, c-Cbl is preferentially expressed in the thymus and functions as an E3-ubiquitin ligase, promoting the ubiquitination and stability of several Cbl-associated proteins (Liu and Chen 2004) . The pTa chain of pre-TCR is expressed at barely detectable levels on the surface of immature thymocytes and its low expression was proposed to be dependent on specific ubiquitination and degradation processes, sustained by the E3 ligase c-Cbl (Panigada et al., 2002) . c-Cbl has been also shown to promote ubiquitin-dependent lysosomal degradation of membrane-associated Notch1 (Jehn et al., 2002) . In this study, we show that c-Cbl targets Notch3 protein to the proteasomal-degradative pathway only in the absence of pTa and that this depends on the cytoplasmic localization and tyrosine phosphorylation state of c-Cbl, being the latter aspect known to be negatively regulated by the protein kinase C y (PKCy) activity (Liu et al., 1999) . We also show that c-Cbl membrane recruitment depends on the presence of a functional Notch3 receptor together with an intact and functional pTa/pre-TCR complex, previously described by us to favor the kinase activity and membrane recruitment of PKCy (Felli et al., 2005) . Finally, we show that Notch3 and pTa physically interact and that this direct relationship could contribute to the maintenance of the constitutive activation of both Notch and pre-TCR signaling pathways in thymocytes, finally also sustained by the loss of c-Cbl-mediated degradation of Notch3.
Results c-Cbl ubiquitin ligase targets N3-IC to the proteasomal degradation pathway depending on the absence of pTa/pre-TCR complex E3 ubiquitin ligases have recently emerged as key regulators of immune cell function (Gay et al., 2008) .
Previous studies described the involvement of c-Cbl and its ubiquitin ligase activity in the regulation of both pTa and Notch1 turnover (Jehn et al., 2002; Panigada et al., 2002) . Thus, we sought to test whether Notch3 protein could be a target of c-Cbl. To this purpose, we cotransfected HEK293 cell lines with N3-IC and c-Cbl expression vectors. As shown in Figure 1a (upper panel), these two proteins are able to physically interact. To assess whether c-Cbl can target Notch3 protein for ubiquitinylation, we tested the immunoprecipitated Notch3 with an anti-Ub antibody (middle panel). Although low levels of constitutively ubiquitinylated Notch3 signal were observed in the absence of c-Cbl (Figure 1b) . Although Notch proteins have been shown to have a fast turnover rate, in our condition, MG132 treatment had a very modest inhibition of Notch3 degradation at 3 h after treatment whereas MG132 had an almost complete inhibition of Notch3 degradation at 5 h after treatment (Figure 1b , compare lanes 11 and 12). To exclude a possible effect of new protein synthesis, we also treated cells with the ribosome inhibitor cycloheximide (CHX) in the presence or absence of the proteasome inhibitor MG132. As shown in Figure 1c , also after CHX treatment, the level of Notch3 protein was lowered by c-Cbl expression (lane 5); interestingly, MG132 is able to inhibit Notch3 degradation also in the presence of CHX (lane 6).
Together these results indicate that c-Cbl-dependent ubiquitinylation of Notch3 may specifically target this protein for proteasomal degradation.
We have previously shown that Notch3 and pTa signaling events are essential for Notch3-mediated T-cell leukemogenesis (Bellavia et al., 2002; Talora et al., 2006) . To assess whether pTa has a role in regulating the c-Cbl-dependent degradation of Notch3, we cotransfected HEK293 cells with N3-IC and c-Cbl in the presence or absence of pTa. Figure 2a shows that the addition of pTa expression vector resulted in the inhibition of the c-Cbl-mediated Notch3 degradation, indicating that enforced expression of pTa negatively regulates c-Cbl activity (Figure 2a) . To evaluate the role of endogenous pTa function in the control of Notch3 expression, we performed knockdown of pTa gene expression in N3-232T cells, an immortalized cell line established from N3-IC-HA transgenic thymocytes, which overexpress exogenous N3-IC, endogenous Notch3 and pTa (Bellavia et al., 2000) . Downregulation of Notch3 expression was achieved by the knockdown of pTa gene expression (Figure 2b ). Importantly, this effect was inhibited by treatment with the proteasome inhibitor MG132 (Figure 2b ). Moreover, we examined the mRNA and protein expression of Notch3 in thymocytes derived from wild-type (wt), tg N3-IC and
) double-mutant mice. Although no significant difference of Notch3 mRNA level was observed in any of these thymocytes, western blot analysis revealed a substantial downregulation of N3-IC protein expression in pTa-deleted thymocytes (Figure 2c ). To test whether Notch3 downmodulation induced by pTa deletion reflects a degradation event or is due to translational regulation, we compared the half-life of N3-IC in a time course study performed on unfractionated thymocytes derived from tg N3-IC and N3-IC/pTa À/À double-mutant mice in the presence of CHX. As shown in Figure 2d , Notch3 expression decreases only after 5 h of CHX treatment in tg N3-IC thymocytes, whereas in N3-IC/pTa À/À thymocytes N3-IC levels are already heavily decreased after 3 h. These results provide evidence that pTa deletion affects N3-IC degradation process. Consistently with this hypothesis, treatment of N3-IC/pTa À/À double-mutant thymocytes with proteasome inhibitor MG132 resulted in an increase of N3-IC protein expression (Figure 2e ). Interestingly, treatment with the lysosome inhibitor chloroquine does not affect the level of N3-IC expression, suggesting the important role of pTa in the regulation of Notch3 degradation process by the 26S proteasome (Figure 2e ). Intriguingly, N3-IC appears to be able to interact with c-Cbl only in thymocytes lacking pTa (Figure 2f ). To explain the lack of interaction between Notch3 and c-Cbl in tg N3-IC thymocytes, we hypothesized that the presence of high levels of pTa, which is able to strongly directly interact with c-Cbl in transgenic thymocytes (Supplementary Figure 1) , might restrain the association between Notch3 and c-Cbl. Overall, these results suggest a critical role of pTa/pre-TCR complex in the regulation of Notch3 degradation, suggesting that the absence of pTa is required to favor N3-IC accessibility to c-Cbl ubiquitin ligase function.
PKCy protein kinase regulates c-Cbl phosphorylation status Previous studies have suggested that tyrosine phosphorylation is required for ubiquitin ligase activity of c-Cbl (Liu et al., 1999; Kassenbrock and Anderson, 2004) . In addition, serine phosphorylation has been shown to reduce tyrosine phosphorylation of c-Cbl leading to inhibition of its activity (Liu et al., 1999) . Thus, tyrosine and serine phosphorylation of c-Cbl leads to opposite functional effects. On the basis of this finding, we analyzed the phosphorylation status of c-Cbl in thymocytes derived from wt, tg N3-IC and N3-IC/ pTa À/À double-mutant mice. Figure 3a shows that c-Cbl is strongly tyrosine-phosphorylated in thymocytes lacking pTa gene, whereas the major serine phosphorylation is observed in tg N3-IC thymocytes. It is known that phorbol ester phorbol 12-myristate 13-acetate (PMA) is able to activate PKC enzymes by binding to their cysteine-rich domain. In addition, PMA is able to induce serine phosphorylation of c-Cbl while favoring reduced tyrosine phosphorylation (Liu et al., 1999) . We previously reported that N3-IC/pTa À/À doublemutant thymocytes display a decreased PKCy kinase activity (Felli et al., 2005) , thus we hypothesized that PKCy is involved in the differential regulation of c-Cbl phosphorylation in tg N3-IC and N3-IC/pTa À/À doublemutant thymocytes. To address this issue, we determined a time course of PMA effects on c-Cbl phosphorylation in N3-IC/pTa À/À double-mutant thymocytes. Figure 3b shows that PMA decreased tyrosine phosphorylation of c-Cbl, allowing the increase of c-Cbl serine phosphorylation level. Interestingly, PMA treatment also caused upregulation of N3-IC expression ( Figure 3c ). Together these data indicate that PKC is involved in the regulation of c-Cbl phosphorylation status, which in turn regulates Notch3 degradation process in the absence of pTa gene.
To validate further our findings and to directly correlate them to PKCy activity, we compared the effects of either dominant-negative (DN) or constitutive Notch3 is constitutively recruited to lipid raft microdomains of thymocytes It has been previously shown that the pre-TCR is able to signal constitutively in the absence of putative ligands on thymic stroma and this correlates with translocation of the pre-TCR into lipid rafts in the plasma membrane (Irving et al., 1998; Saint-Ruf et al., 2000) . Recently, Notch1 has been also shown to localize in lipid rafts of activated T lymphocytes (Benson et al., 2005) . On the basis of these results, we sought to determine whether Notch3 is recruited in lipid raft microdomains. After a processing by a furine-like protease activity in the Golgi apparatus (S1 cleavage), Notch receptors localize at the cell membrane as a noncovalent heterodimer, comprising an extracellular subunit, the N-terminal fragment (N EC ), and a transmembrane unit, the C-terminal fragment (N TM ) (Blaumueller et al., 1997) . In addition, by S2 and S3 cleavage respectively, the N EC fragment is released and the N TM fragment is further processed to release the N3-IC activated form. To test which N3 EC , N3
TM and N3 IC forms were recruited in lipid raft microdomains, we used subunit-specific antibodies. Here we show that Notch3 receptor is constitutively present not only in the whole membrane compartment, but also in lipid rafts fraction of Notch3-overexpressing N3-232T cells (Figure 4a ). The detection of both N3 EC and N3
TM fragments in the lipid rafts point out that the full length (N3 FL ) Notch3 receptor is specifically recruited to the raft. Conversely, the N3 IC fragment is not detected in the rafts fraction (Figure 4a ).
To further verify that Notch3 is recruited to lipid raft microdomains, we performed confocal microscopy analysis on thymocytes derived from wt and tg N3-IC mice. Thymocytes were labeled with fluorochromelabeled cholera toxin B that targets the ganglioside GM1, specifically localized to the raft domains, and with anti-Notch3 antibody. Our assay revealed the colocalization of Notch3 with cholera toxin B subunit in all the samples analyzed ( Figure 4b , left panel). However, although in unstimulated wt thymocytes the merged staining appears finely diffuse in the cell membrane, in anti-CD3-treated wt thymocytes the merged staining indicates the clusterization typical of activated thymocytes. This clusterization appears even more evident in tg N3-IC resting thymocytes, which thus behave as activated cells and suggest a possible role of Notch3 in sustaining and/or triggering thymocyte activation. The constitutive targeting of ZAP-70 to rafts of resting N3-IC thymocytes supports the activation status. In additional experiments, the thymocytes were also washed, lysed and subjected to sucrose density gradient centrifugation to isolate lipid raft and Brij58-soluble c-Cbl activity in Notch3-dependent leukemia S Checquolo et al fractions, then subjected to SDS-PAGE and probed to detect Notch3 expression using N3 EC -specific antibody. As shown in Figure 4b (right panel), we found that in both tg N3-IC thymocytes and in anti-CD3 treated wt thymocytes Notch3 receptor is localized to lipid rafts fraction. The presence of pTa in lipid rafts of wt thymocytes is constitutive, as previously described (Saint-Ruf et al., 2000; Panigada et al., 2002) , and appear more evident after rafts clusterization. Interestingly, pTa is constitutively localized to lipid rafts fraction in tg N3-IC thymocytes (Figure 4b, right panel) .
It has been shown that c-Cbl is specifically recruited into rafts microdomains following pre-TCR signaling (Panigada et al., 2002) . To investigate whether pre-TCR defective signaling would affect the recruitment of Notch3 and c-Cbl to raft microdomains, we analyzed the targeting of Notch3 receptor in raft microdomains in both TCR-b-deficient cell line SCIET27, lacking pre-TCR expression and derived from severe combined immunodeficient thymocytes, and the TCR-b-transfected daughter cell line SCB29 (Groettrup et al., 1992) . By using N3
EC -specific antibody we found that Notch3 receptor is targeted to rafts fraction of SCB29 cell line, whereas its raft translocation was barely seen in SCIET27 cell line (Figure 4c ). Consistent with this, Notch3 was targeted to lipid rafts in tg N3-IC mice, whereas its rafts translocation was barely seen in N3-IC/ pTa À/À double-mutant mice-derived cells (Figure 4d , right panel). However, Notch3 full-length expression in whole-cell extracts remained unchanged in either the absence or the presence of pTa (Figure 4d, left panel) . To investigate whether pTa-dependent rafts translocation of Notch3 depends by a direct protein-protein interaction, we analyzed the interaction of Notch3 and pTa. Immunoprecipitates derived from HEK293 cell line transfected with N3-IC and pTa expression vectors showed a direct interaction between Notch3 and pTa ( Figure 4e, left panel) . Consistent with this, endogenous Lck and anti-tubulin immunoblotting were used as a control of fractionation; anti-b-actin immunoblotting was used to monitor sample loading. WCE, whole-cell extracts; C, cytosol; M, membrane; R, rafts; NR, nonrafts; FL, full-length receptor; EC, extracellular fragment; TM, transmembrane fragment; IC, intracellular fragment; un, untransfected cells; tr, transfected cells.
c-Cbl activity in Notch3-dependent leukemia S Checquolo et al Notch3 and pTa association was also detected in 2017 pre-T-cell line (Spolski et al., 1988 ) that express high level of both Notch3 and pTa (Bellavia et al., 2007) (Figure 4e , right panel). Altogether these observations suggest that the interaction of Notch3 and pTa proteins is possible at the cell surface of thymocytes, where the lipid rafts represent the molecular platform in which TCR or pre-TCR components cluster to trigger intracellular signaling. On the basis of this observation, Notch3/pTa association may contribute to sustain the activation of pre-TCR and Notch signaling.
Notch3 promotes c-Cbl recruitment to thymocyte lipid rafts depending on pTa/pre-TCR expression Because it has been shown that c-Cbl is specifically recruited into rafts following pre-TCR signaling (Panigada et al., 2002) , we hypothesized that Notch3 and pre-TCR could determine cooperatively the translocation of c-Cbl into rafts. To address this issue, we analyzed thymocytes derived from wt and tg N3-IC mice. Subcellular fractionation experiments revealed the selective enrichment of c-Cbl in the rafts fraction of tg N3-IC thymocytes when compared to wt thymocytes (Figure 5a ). We observed the same level of c-Cbl accumulation into rafts of resting N3-IC thymocytes and anti-CD3-stimulated wt thymocytes, suggesting the presence of a constitutive aggregation of lipid rafts, thus constitutive activation, in thymocytes of tg N3-IC mice. To analyze further the possible role of Notch3 in sustaining the c-Cbl translocation into rafts microdomains, we treated N3-232T cells with the calcium ionophore A23187 that, by preventing Notch S1 cleavage event in trans-Golgi network, leads to the accumulation of full-length precursor in cytoplasmic compartment (Logeat et al., 1998) . Biochemical isolation of lipid raft and Brij58-soluble fractions revealed the decreased recruitment of c-Cbl protein to the raft fractions of A23187-treated cells (Figure 5b ). Interestingly, after A23187 treatment the endogenous N3 EC and N3 TM fragments are not detectable in membrane raft, whereas Notch3 is detected as S1-uncleaved full-length precursor Overall, these data suggest that the targeting of c-Cbl to lipid rafts depends on Notch3 and requires the presence of pTa. Moreover, they suggest that the direct interaction between Notch3 and c-Cbl proteins is possible only outside of rafts fraction (Figure 5d ).
Discussion
The role of Notch signaling in inducing T-ALL is well established. Nevertheless, the molecular mechanisms priming and/or regulating Notch signaling remain undefined. Although Notch3 transgenic mice recapitulate cellular and molecular features of T-ALL and Notch3 overexpression was observed in virtually all patients with T-ALL (Bellavia et al., 2002) , gene mutations or evident gene rearrangements of Notch3 have never been observed, diversely from what happens for Notch1 (Weng et al., 2004) . Altered degradation process may be responsible for protein overexpression, however, no data are available, as yet, addressing the mechanisms regulating Notch3 processing/degradation, whose deregulation may be responsible of its increased expression in leukemic cells and susceptible to become therapeutic targets.
In this study, we analyzed this aspect, focusing our attention on the E3 ubiquitin ligase c-Cbl, known to be involved in the ubiquitinylation and/or degradation of Notch1 and pTa proteins (Jehn et al., 2002; Panigada et al., 2002) . Our previous studies showed the importance of combined expression of Notch3 and pTa in sustaining a number of oncogenic pathways responsible for T-cell leukemogenesis (Bellavia et al., 2002; Talora et al., 2006) . In this report, we further investigate such a relationship and show that Notch3 and pTa are able to physically interact and this direct association allows the recruitment of c-Cbl to the lipid rafts in tg N3-IC thymocytes. Interestingly, previous observations have shown that c-Cbl is constitutively associated with detergent-insoluble fractions of lymphoid or myeloid cells in leukemic patients, whereas in healthy subjects it is detected only in the cytosolic fractions (Brizzi et al., 1998) .
Moreover, defects in ubiquitin-dependent proteolysis have been shown to result in a variety of human diseases, including cancer. Indeed, several oncoproteins exhibit loss of c-Cbl binding site and hence appear to become refractory to c-Cbl-mediated negative regulation, leading to enhanced downstream signaling and oncogenesis (Peschard and Park, 2003) .
Notably, similar to what observed in human healthy subjects, we show here that in N3-IC/pTa À/À doublemutant mice, which do not develop leukemia, c-Cbl is preferentially present in the cytosolic fraction. Furthermore, the observation that N3-IC physically interacts with c-Cbl ligase protein only in the absence of a functional pTa/pre-TCR complex, correlating with the increased proteasomal degradation of N3-IC in the same conditions, supports the hypothesis that c-Cbl may be responsible for such degradation. Several studies have shown the pivotal role of tyrosine phosphorylation of c-Cbl in sustaining its E3 ligase activity (Liu et al., 1999) . In accord with this, we observed higher levels of c-Cbl tyrosine phosphorylation in N3-IC/pTa À/À double-mutant thymocytes, which also display increased N3-IC degradation. We hypothesize that the mechanism that could allow the tyrosine phosphorylation of c-Cbl and its ubiquitin activity upon Notch3 in the absence of pTa could involve the PKCy, which has been previously shown to negatively regulate the status of c-Cbl tyrosine phosphorylation in Jurkat-TAg cells (Liu et al., 1999) . We previously reported that PKCy kinase is constitutively active in tg N3-IC mice and requires a functional pre-TCR to be targeted to the cell membrane, where it colocalizes with pTa. In contrast, in N3-IC/pTa À/À double-mutant mice, PKCy has a preferential cytosolic localization that also associates with a reduced kinase activity (Felli et al., 2005) . Here we show that PKCy is able to influence the c-Cbl phosphorylation status, finally regulating the c-Cbl-dependent degradation of N3-IC. Overall our results suggest that in tg N3-IC thymocytes c-Cbl is constitutively recruited to the lipid rafts fraction and appears to have a limited capacity to act as E3 ubiquitin ligase toward Notch3. Interestingly, a direct interaction between Notch3 and c-Cbl, necessary to allow Notch3 ubiquitinylation, appears to be possible in cytosolic fraction only when rafts are disrupted by MbCD. In contrast, in N3-IC/pTa À/À double-mutant thymocytes, in which c-Cbl has a preferential cytosolic localization, it would preferentially act as an E3 ligase, targeting N3-IC to the proteasomal degradation and preventing leukemia development. Consequently, our data provide evidence for a hypothetical model, where the different sub-cellular localization of c-Cbl, which depends on the presence or absence of pTa, that also regulates PKCy kinase activity, may correlate with its different functional role upon Notch3 (Figure 6 ). 
Materials and methods
Mice tg N3-IC (Bellavia et al., 2000) , pTa À/À (Fehling et al., 1995) 
Plasmids and cell transfection
Transient transfection experiments were performed by Lipofectamine 2000 kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The expression vectors for N3-IC (Bellavia et al., 2000) , c-Cbl (Ota et al., 2000) , DNPKCy and CA-PKCy (Hehner et al., 2000) were previously described. The fragment containing the entire pTa sequence was amplified by PCR from mouse mRNA using the following primers: 5 0 -GCGAACTGGGTCATGCTTCTCCA-3 0 and 5 0 -GCGCTATGTCCAAATTCTGTGGG-3 0 . The amplified insert (620 bp) was ligated in pcDNA3.1/V5-His-TOPO plasmid. The pcDNA3.1 vector was used as an empty control vector.
Cell lines and treatments N3-232T (Bellavia et al., 2000) , pre-T 2017 (Spolski et al., 1988) , pre-T-SCIET27 (TCRb-deficient) and SCB29 (Aifantis et al., 2001 ) cell lines were previously described. N3-232T cells were treated with 2 mM furine-like inhibitor (A23187; Calbiochem, San Diego, CA, USA) for 24 h before sucrose extraction. In some cases, cells were treated with different compounds: 30 mM proteasome inhibitor MG132 (Calbiochem); 30 mM lysosome inhibitor chloroquine (Sigma-Aldrich, Poole, UK); 10 mg/ml ribosome inhibitor CHX for the times indicated. N3-IC/pTa À/À double-mutant thymocytes were treated with PMA at a final concentration of 50 ng/ml for the times indicated. For T-cell activation, thymocytes were incubated with anti-CD3 (145-2C11; BD Pharmingen, San Diego, CA, USA) antibody at a final concentration of 10 mg/ml, for 15 min at 37 1C.
siRNA silencing Cells were transfected with 5 nM siRNAs for validated mouse Notch3, pTa and corresponding control scrambled siRNAs (Dharmacon, Lafayette, CO, USA) using Hy-perfect transfection reagent (Qiagen, Hilden, Germany) following the manufacturer's recommendations. Cells were analyzed 72 or 144 h after transfection.
Protein extract, immunoprecipitation and immunoblotting
The following antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA): anti-a-tubulin, antip56 Lck , anti-Ub, anti-Cbl, anti-HA. Anti-b-actin and anti-flag were purchased from Sigma-Aldrich. Anti-N3 EC (5E1) and rabbit polyclonal anti-N3 IC (BC4) were kindly provided by Professor A Joutel (Joutel et al., 2004) . Anti-ZAP-70, antiphosphotyrosine and anti-phosphoserine PKC were purchased from Cell Signaling (Danvers, MA, USA). Anti-pTa, kindly provided by H von Bohemer (Aifantis et al., 1998) . Protein extract preparation and immunoprecipitation assay were described elsewhere (Felli et al., 2005) . The ubiquitination assay has been carried out under appropriate denaturing conditions (buffer with 1.5% SDS added). In presence of a functional pre-TCR/Notch3 relationship, c-Cbl is able to translocate to the rafts compartment, where it is preferentially phosphorylated in serinerich motifs through protein kinase C y (PKCy). In these conditions c-Cbl seems to lack its E3 ubiquitin ligase upon Notch3, thus sustaining the oncogenic role of Notch3 and pTa relationship with respect to T-cell leukemogenesis. (b) In the absence of pre-TCR, c-Cbl localizes preferentially in cytosolic fraction. In addition, deletion of pTa results in reduction of PKCy activity that in turn favors tyrosine phosphorylation of c-Cbl and its increased E3 ubiquitin ligase activity upon Notch3-IC, targeting it to proteasomal-degradative pathway and contributing to the rescue of T-cell leukemia. P-tyr, tyrosine phosphorylation; P-Ser, serine phosphorylation; Ub, ubiquitination.
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